Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration

4 Jun 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to FOXO transcription factor regulation
Share to interferon and immune responses

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35671810
DOI: 10.1016/j.lfs.2022.120692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migrationPMID 35671810Read ↗

KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2Semantic proximity Read ↗

EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like propertiesSemantic proximity Read ↗

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challengesSemantic proximity Read ↗

Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genesSemantic proximity Read ↗

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasisSemantic proximity Read ↗

A comprehensive investigation of m <sup>6</sup> A regulators prognostic value and associated molecular pathways in breast invasive cancerSemantic proximity Read ↗

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancerSemantic proximity Read ↗

miR-486-5p regulates cell proliferation and migration in breast cancerSemantic proximity Read ↗

TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathwaySemantic proximity Read ↗

The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathwaysSemantic proximity Read ↗

FBXL6 degrades phosphorylated p53 to promote tumor growthSemantic proximity Read ↗

BIRC5 is a prognostic biomarker associated with tumor immune cell infiltrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.